Stock Quote (NASDAQ: VTUS)
Price:
10.50
Change:
- 0.76
Day High:
11.37
Day Low:
10.10
Volume:
300,000
4:00 PM ET on May 18, 2012
Delayed at least 20min., by eSignal.
Contact the Board

SHAREHOLDER TOOLS
Briefcase Printed Materials Email Alerts
Download Center snapshot RSS Mobile Investor

PROXY STATEMENT
2011 Annual Report
2012 Proxy Statement

You can contact Ventrus Bioscience, Inc.'s Board of Directors to provide comments, to report concerns, or to ask a question, at the following address.

Corporate Secretary
Ventrus Bioscience, Inc.
787 7th Avenue 48th Floor
New York, NY 10019
United States

You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a shareholder, customer, supplier, or other interested party.

Communications are distributed to the Board, or to any individual directors as appropriate, depending on the facts and circumstances outlined in the communication. In that regard, the Ventrus Bioscience, Inc. board of directors has requested that certain items which are unrelated to the duties and responsibilities of the board should be excluded, such as:

  • Product complaints
  • Product inquiries
  • New product suggestions
  • Resumes and other forms of job inquiries
  • Surveys
  • Business solicitations or advertisements

In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.

You may also communicate online with our Board of Directors as a group.

Please submit your comment using the form below. * Required fields

 
 
 
 
 
 
This helps Ventrus Bioscience, Inc. prevent automated submissions.
 
 
Home About Ventrus Product Pipeline Contact Investor Relations